荟萃分析
医学
出版偏见
子群分析
视网膜病变
系统回顾
内科学
梅德林
政治学
法学
糖尿病
内分泌学
作者
Alireza Fatemi,Ali Taghipour,Yasmin Yazdooei,Mohammad Javad Fatemi,Akram Hashemi,Nafiseh Abdolahi
标识
DOI:10.1111/1756-185x.70253
摘要
ABSTRACT Background and Objectives Studies have indicated a potential link between retinopathy and systemic sclerosis (SSc), but the precise nature of this association remains unclear. This systematic review and meta‐analysis aims to synthesize available evidence to evaluate the relationship between SSc and retinopathy. Methods A systematic search was conducted across four major databases and gray literature to collect all relevant studies. The quality of the selected articles was assessed for risk of bias using standardized tools. A meta‐analysis was performed using standardized mean difference (Std. Mean Difference) to estimate the association between retinopathy and SSc. Additional analyses for heterogeneity, sensitivity, subgroups, and publication bias were also conducted. Results Twelve studies (359 cases, 314 controls) were included in the systematic review. A meta‐analysis of eight studies found a nonsignificant and negligible association (pooled Std. Mean Difference = 0.08; 95% CI = −0.31 to 0.48; p = 0.67) between SSc and retinopathy, with no publication bias ( p = 0.5362). Differences in Std. Mean Difference were observed in subgroup analyses but did not sufficiently explain the heterogeneity. Conclusions The findings suggest no strong association between retinopathy and SSc. While some subgroup analyses revealed potential variations, they did not fully clarify the observed heterogeneity. Further research with larger, well‐designed studies is necessary to determine whether retinopathy could serve as a biomarker for SSc. Systematic Review Registration Number ( PROSPERO ) CRD42024529644 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=529644 .
科研通智能强力驱动
Strongly Powered by AbleSci AI